MedTrace Logo

No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation

NCT04792424 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-11-14

No results posted yet for this study

Summary

Do no monitor of post-circuit ionized calcium affact the filter life time of continueous renal replacement therapy with regional citrate anticoagulation circuit? A randomized control trial

Conditions

  • Regional Citrate Anticoagulation
  • Ionized Calcium
  • Continuous Renal Replacement Therapy

Interventions

OTHER

Regional citrate anticoagulation

Starting RCA 4 mmol/L (adjust the rate by BFR)

DRUG

Vasopressor

Vasopressors such as Norepinephrine, dopamine, milrinone, dobutamine

DRUG

Antibiotic

Antibacterial agents deemed appropriate by physicians in the ICU

DEVICE

Dialysis with continuous renal replacement therapy

Prismaflex

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-05-30
Completion
2022-06-15

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792424 on ClinicalTrials.gov